Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

Presentation THT 2026

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Presenter: Makiko Nakamura

March 04, 2026

Presentation THT 2026

Indication-Specific Outcomes With Impella 5.5

Presenter: Paul Kaddissi

March 03, 2026

Presentation THT 2026

Updates on the Spectrum of Impella Devices

Presenter: Jane E. Wilcox

March 03, 2026

Presentation THT 2026

UltraSight PVAD IQ Machine Learning Algorithm Accurately Identifies Impella Micro-axial Flow Pump Depth Across the Aortic Valve on Ultrasound Imaging: An Early Clinical Feasibility Study

Presenter: Luca Baldetti

March 03, 2026

Presentation THT 2026

Thirty-Day Mortality With Impella Versus Intra-Aortic Balloon Pump in STEMI-Related Cardiogenic Shock: A Systematic Review

Presenter: Hriday Shah

March 02, 2026

Presentation THT 2026

Impella Use for Ventricular Unloading During VA-ECMO Compared With VA-ECMO Alone: An Analysis of the American Heart Association Cardiogenic Shock Registry (AHA-CSR)

Presenter: Rahul Gunukula

March 02, 2026

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

Presentation THT 2025

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Presenter: Jacob Abraham

February 12, 2025

Presentation THT 2025

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Presenter: Miguel Woodham

February 12, 2025

Presentation THT 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Presenter: Katherine Wood

February 12, 2025

Presentation THT 2025

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Presentation THT 2025

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Presenter: Tahira Qadeer

February 11, 2025

Presentation THT 2025

Impella 5.5: A GameChanger for Cardiogenic Shock

Presenter: Jerome Crowley

February 11, 2025

Presentation THT 2025

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Presenter: Manreet Kanwar

February 11, 2025

Presentation THT 2024

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT 2024

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Presenter: Justin Fried

March 05, 2024

Advertisement

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Indication-Specific Outcomes With Impella 5.5

Updates on the Spectrum of Impella Devices

UltraSight PVAD IQ Machine Learning Algorithm Accurately Identifies Impella Micro-axial Flow Pump Depth Across the Aortic Valve on Ultrasound Imaging: An Early Clinical Feasibility Study

Thirty-Day Mortality With Impella Versus Intra-Aortic Balloon Pump in STEMI-Related Cardiogenic Shock: A Systematic Review

Impella Use for Ventricular Unloading During VA-ECMO Compared With VA-ECMO Alone: An Analysis of the American Heart Association Cardiogenic Shock Registry (AHA-CSR)

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Impella 5.5: A GameChanger for Cardiogenic Shock

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content